Clinical Trial Update: Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating amiodarone to prevent atrial fibrillation in patients undergoing surgery for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN